Christine Anne

Title: Christine Anne: Innovator in Botulinum Toxin Research

Introduction

Christine Anne is a notable inventor based in Chatenay Malabry, France. She has made significant contributions to the field of botulinum toxin research, holding 2 patents that focus on innovative compounds and methods for detecting and inhibiting the activity of botulinum toxins.

Latest Patents

Her latest patents include the development of type B botulism toxin inhibitors. These novel compounds are characterized by their general formula (I) and possess inhibitory properties against type B botulism toxin activity. Additionally, she has created methods for the preparation of these compounds and corresponding pharmaceutical compositions. Another significant patent involves a peptide substrate identified by type BoNT/B botulinus toxin. This substrate is designed for assaying and detecting the toxin or its corresponding inhibitors, incorporating a fragment of formula PYA-(Z)-pNF, which is cleavable by the toxin.

Career Highlights

Christine has worked with prestigious organizations such as the Institut National de la Santé et de la Recherche Médicale and the Centre National de la Recherche Scientifique. Her work in these institutions has been pivotal in advancing research in her field.

Collaborations

Throughout her career, Christine has collaborated with esteemed colleagues, including Bernard P. Roques and Serge Turcaud. Their joint efforts have contributed to the advancement of knowledge and technology in botulinum toxin research.

Conclusion

Christine Anne's innovative work in the field of botulinum toxin research has led to significant advancements, as evidenced by her patents and collaborations. Her contributions continue to impact the scientific community and enhance our understanding of this important area of study.